•
Mar 31, 2023

Seres Therapeutics Q1 2023 Earnings Report

Total Revenue
-$522K
Previous year: $1.49M
-135.0%
EPS
-$0.57
Previous year: -$0.61
-6.6%
Gross Profit
-$4.13M
Previous year: $517K
-898.6%
Cash and Equivalents
$94.8M
Previous year: $153M
-38.1%
Free Cash Flow
-$80.7M
Previous year: -$69.4M
+16.2%
Total Assets
$270M
Previous year: $320M
-15.5%

Seres Therapeutics

Seres Therapeutics